Linda Palczuk
Director/Board Member chez AVADEL PHARMACEUTICALS PLC
Fortune : 885 036 $ au 31/03/2024
Profil
Linda S.
Palczuk is an Independent Director at Avadel Pharmaceuticals Plc and the Chief Operating Officer at Envara Health, Inc. She was previously the President & Chief Executive Officer at Osiris Therapeutics, Inc., Vice President-Sales & Marketing at AstraZeneca Pharmaceuticals LP, and Chief Operating Officer at Verrica Pharmaceuticals, Inc. Palczuk holds an undergraduate degree from Franklin & Marshall College and an MBA from Alfred Lerner College of Business & Economics.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/09/2023 | 52 400 ( 0,03% ) | 885 036 $ | 31/03/2024 |
Postes actifs de Linda Palczuk
Sociétés | Poste | Début |
---|---|---|
AVADEL PHARMACEUTICALS PLC | Director/Board Member | 01/07/2018 |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Chief Operating Officer | 01/01/2019 |
Anciens postes connus de Linda Palczuk
Sociétés | Poste | Fin |
---|---|---|
VERRICA PHARMACEUTICALS INC. | Chief Operating Officer | 22/04/2019 |
OSIRIS THERAPEUTICS, INC. | Chief Executive Officer | 09/02/2018 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Sales & Marketing | 01/03/2015 |
Formation de Linda Palczuk
Franklin & Marshall College | Undergraduate Degree |
Alfred Lerner College of Business & Economics | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
Entreprise privées | 3 |
---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Envara Health, Inc.
Envara Health, Inc. Pharmaceuticals: OtherHealth Technology Envara Health, Inc. is a life science and clinical nutrition company based in Malvern, PA. Envara Health is dedicated to addressing the widespread problem of malabsorption and nutritional deficiencies through breakthrough science and clinical evidence. The company's first product, Encala, is a medical food that provides healthy calories, including essential fatty acids, in an easily absorbable structure. Encala has been tested in multiple clinical studies and has been shown to improve the absorption of other fat and nutrients from corresponding meals. Envara Health's validated structured lipid platform is enabling the development of a suite of precision nutrient products that will address a broad spectrum of disease states, in both humans and animals. The company was founded in 2017 by Jim O'Connell and Virginia A. Stallings. Jim O'Connell has been the CEO since 2017. | Health Technology |